| Application no. and date | 09075102.5 (espacenet) (Federated) (European Patent Register), 20060619 | | Patent/reg. no. and date | DK/EP 2100618, 20140212 | | Publication date | 20090916 | | Priority no. and date | US 691920 P, 20050617 | | EP pub. no. and date |
EP 2100618 20090916 | | Effective date | | | Applicant/owner | Philadelphia Health and Education Corporation
d/b/a Drexel University College of Medicine, 245 North 15th Street
Philadelphia, PA 19102, US,
ImClone LLC, 450 East 29th Street, 12th Floor
New York, NY 10016, US | | Applicant ref. no. | P81400470DK00E | | Inventor | LOIZOS, Nick, 41 Natick Street
Staten Island, NY 10306, US,
Fatatis, Alessandro, 1140 N. Woodbine Avenue
Penn Valley
Pennsylvania 19072, US,
Dolloff, Nathan Graeme, 116 West Hillcrest Avenue
Haverton, Pennsylvania 19083, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Anti-PDGFR-alpha-antistof til anvendelse ved behandling af metastatisk knoglekræft | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
